http://www.biorn.org/ Newsticker en http://www.biorn.org/EXT:tt_news/ext_icon.gif http://www.biorn.org/ Newsticker TYPO3 - get.content.right http://blogs.law.harvard.edu/tech/rss Mon, 23 Aug 2010 11:05:00 +0200 http://www.biorn.org/index.php?id=100&tx_ttnews%5Btt_news%5D=550&cHash=d5d2f226ea7b50fb8dfb294ccbca84df Mannheim/Basel (D/CH) | Acquisition further strengthens Roche’s global leadership in tissue-based cancer diagnostics and research Mon, 23 Aug 2010 11:05:00 +0200 http://www.biorn.org/index.php?id=100&tx_ttnews%5Btt_news%5D=546&cHash=ca2e2fc21aef700b89ef8cd8a776072f World Experts on Regional Innovation gather in Heidelberg: Join the Annual Conference of The Technopolicy Network! www.technopolicy.net/annualconference Wed, 18 Aug 2010 09:34:00 +0200 http://www.biorn.org/index.php?id=100&tx_ttnews%5Btt_news%5D=529&cHash=067221c73e59f8475e0f430b5bb93879 Berlin (G) | Glycotope GmbH, has received regulatory approval by German and Italian regulatory authorities for a Phase I study of Glycotope´s next generation antibody CetuGEX™ (GT-MAB 5.2-GEX) Wed, 04 Aug 2010 14:07:00 +0200 http://www.biorn.org/index.php?id=100&tx_ttnews%5Btt_news%5D=499&cHash=e2ac6489e1a77b20150fb7f3b592bd45 Heidelberg (G) | When Harald zur Hausen was awarded the Nobel Prize for Medicine in 2008, Manfred Lautenschläger offered to support the Nobel laureate’s scientific work by funding a new research team. Thu, 15 Jul 2010 13:05:00 +0200 http://www.biorn.org/index.php?id=100&tx_ttnews%5Btt_news%5D=441&cHash=d5000a05347997b264a4066325865537 Heidelberg (Germany and Lexington) | febit today announced a restructuring as a consequence of it′s focus on blood-based microRNA biomarker discovery, febits major business development in 2009/2010, and on partnerships and intellectual... Wed, 23 Jun 2010 11:29:00 +0200 http://www.biorn.org/index.php?id=100&tx_ttnews%5Btt_news%5D=422&cHash=0c706ed3b7ff727fa8d318168a973ccf CARLSBAD (USA)/ Heidelberg (G) | Life Technologies Corporation and DKFZ, today announced their collaboration to create the National High-Throughput Sequencing Center. Fri, 04 Jun 2010 16:33:00 +0200 http://www.biorn.org/index.php?id=100&tx_ttnews%5Btt_news%5D=418&cHash=2402e1a9c96bdc1c6edaea2b0cecf1a8 Heidelberg (G) | Peer-Reviewed Publication by Professor Marcus Peter of the University of Chicago Shows Cancer Cells Depend on the Constitutive Activity of CD95, Stimulated by Cancer-Produced CD95L. Thu, 27 May 2010 14:22:00 +0200 http://www.biorn.org/index.php?id=100&tx_ttnews%5Btt_news%5D=407&cHash=4256578b23e47971c1e3460aa566c457 Heidelberg (G) | The DKFZ has published the largest study worldwide on the combined risk of diabetes and cancer. People affected by type 2 diabetes have an elevated risk of 24 of the types of cancer studied. Fri, 21 May 2010 11:00:00 +0200 http://www.biorn.org/index.php?id=100&tx_ttnews%5Btt_news%5D=383&cHash=cec51a9bc24e55ffab2b08bc17b92cba Heidelberg (G) | Scientists of the DKFZ have discovered that bioavailability and efficacy of the blood cancer drug azacytidine increase when the substance is coupled to a fatty acid. Thu, 06 May 2010 16:21:00 +0200 http://www.biorn.org/index.php?id=100&tx_ttnews%5Btt_news%5D=379&cHash=c0740da34d2460ec57a50cd2d15151fc Heidelberg (G) | Affimed Therapeutics AG have raised over 20 million Euros from five investors in a Series C financing round. The total will be used to fund their antibody technology. Thu, 29 Apr 2010 14:46:00 +0200